IMAGINE
Innovative Science | Differentiated Therapies | Improved Outcomes
AT INMAGENE
We are pioneering a new generation of therapies with best-in-class potential across a spectrum of immunological and inflammatory diseases. Leveraging external innovation and our proprietary QuadraTek® platform, we are developing differentiated treatments that have the potential to offer better outcomes to patients.
Our science
Our lead candidates have been engineered to address a broad spectrum of immune and inflammatory indications while optimizing safety, efficacy, and convenience.
Pipeline
We are developing a new generation of therapies for patients living with immunologic and inflammatory diseases.
Partnerships
Join our mission to deliver better therapies to patients in need.
News
Explore our most recent updates.
February 3, 2024